68 related articles for article (PubMed ID: 913955)
1. Inhibitory effect of mepitiostane on the growth of mammary tumor of a rat.
Takatani O; Kumaoka S
Gan; 1977 Jun; 68(3):337-41. PubMed ID: 913955
[TBL] [Abstract][Full Text] [Related]
2. 2alpha, 3alpha-epithio-5alpha-androstan-17beta-yl 1-methoxycyclopentyl ether in the treatment of advanced breast cancer: Japanese Cooperative Group of Hormonal Treatment for Breast Cancer.
Cancer; 1978 Feb; 41(2):758-60. PubMed ID: 343913
[TBL] [Abstract][Full Text] [Related]
3. 2Alpha, 3alpha-epithio-5alpha-androstan-17beta-YL 1-methoxycyclopentyl ether (10364-S), a new orally active anti-estrogenic steroid.
Miyake T; Hori T; Kato G; Ide M; Uchida N; Yamaguchi K
Steroids; 1974 Jun; 23(6):929-37. PubMed ID: 4836439
[No Abstract] [Full Text] [Related]
4. Antitumor effect of two oral steroids, mepitiostane and fluoxymesterone, on a pregnancy-dependent mouse mammary tumor (TPDMT-4).
Matsuzawa A; Yamamoto T
Cancer Res; 1977 Dec; 37(12):4408-15. PubMed ID: 922732
[TBL] [Abstract][Full Text] [Related]
5. 2alpha, 3alpha-epithio-5alpha-androstan-17beta-yl 1-methoxycyclopentyl ether (10361-S), a new orally active anabolic-androgenic steroid.
Miyake T; Uchida K; Kakushi H; Nomura Y; Kadowaki M
Jpn J Pharmacol; 1974 Aug; 24(4):551-8. PubMed ID: 4455965
[No Abstract] [Full Text] [Related]
6. Epithioandrostanol on mammary tumors of rats and mice.
Takatani O; Kumaoka S; Yamaguchi K
Gan; 1973 Jun; 64(3):305-7. PubMed ID: 4730599
[No Abstract] [Full Text] [Related]
7. Therapeutic value of mepitiostane in the treatment of advanced breast cancer.
Inoue K; Okazaki K; Morimoto T; Hayashi M; Uyama S; Sonoo H; Koshiba Y; Takihara T; Nomura Y; Yamagata J; Kondo H; Kanda K; Takenaka K
Cancer Treat Rep; 1978 May; 62(5):743-5. PubMed ID: 657160
[TBL] [Abstract][Full Text] [Related]
8. [Proceedings: Clinical evaluation of a new protein anabolic steroid, 2 alpha-3 alpha-epithio-5 alpha-androstan-17 beta-yl, 1, -methoxycyxlopentyl ether (10364-S)].
Iwai K; Honda H; Yamada S; Fukase M
Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):501. PubMed ID: 4476529
[No Abstract] [Full Text] [Related]
9. [Proceedings: Clinical experience with administration of 2 alpha, 3 alpha- epithio-5 alpha-androstan-17 beta- yl, 1-methoxy-cyclopentyl ether (10364-S) in breast diseases].
Izuo M; Okada T; Suemasu K; Fujimori M
Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):509. PubMed ID: 4476537
[No Abstract] [Full Text] [Related]
10. Endocrine adjuvant therapy with the antiestrogen, mepitiostane, inoperable breast cancer patients on the basis of estrogen receptor assay.
Nomura Y; Yamagata J; Kondo H; Takenaka K
Gan; 1978 Apr; 69(2):281-2. PubMed ID: 680466
[No Abstract] [Full Text] [Related]
11. Proceedings: 2 alpha, 3 alpha-epithio-5alpha-androstan-17beta-YL 1-methoxy-cyclophenyl ether (10364-S), a new orally active anabolic-androgenic steroid.
Miyake T; Uchida K; Kakushi H; Nomura Y; Kadowaki M
Jpn J Pharmacol; 1974; 24(0):s:130. PubMed ID: 4545688
[No Abstract] [Full Text] [Related]
12. Inhibited growth in vivo of a mouse pregnancy-dependent mammary tumor (TPDMT-4) by an antiestrogen, 2alpha, 3alpha-epithio-5alpha-androstan-17beta-ol (10275-S).
Matsuzawa A; Yamamoto T
Cancer Res; 1976 May; 36(5):1598-606. PubMed ID: 178425
[TBL] [Abstract][Full Text] [Related]
13. 2 ,3 - Epithio-5 -androstan-17 -ol in the treatment of advanced breast cancer.
Fujimori M
Cancer; 1973 Apr; 31(4):789-92. PubMed ID: 4574661
[No Abstract] [Full Text] [Related]
14. [Effect of an oral anti-estrogen agent (mepitiostane) on the regression of intracranial meningiomas in the elderly].
Miyai M; Takenaka K; Hayashi K; Kato M; Uematsu K; Murai H
Brain Nerve; 2014 Aug; 66(8):995-1000. PubMed ID: 25082321
[TBL] [Abstract][Full Text] [Related]
15. Independent regulation of growth and steroid receptors in uterus and mammary tumors of rats.
Janssens JP; Billiet G; Bonte J; De Loecker W
Anticancer Res; 1983; 3(6):385-91. PubMed ID: 6230984
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of aplastic anemia with mepitiostane (author's transl)].
Toyama K; Kaneko J; Suzuki H; Negishi M; Nakada I; Tobita K; Katayama T
Rinsho Ketsueki; 1979 Feb; 20(2):121-7. PubMed ID: 439410
[No Abstract] [Full Text] [Related]
17. Antiestrogenic and antitumor effects of droloxifene in experimental breast carcinoma.
Kawamura I; Mizota T; Mukumoto S; Manda T; Masuda K; Nakamura T; Kubota H; Matsumoto S; Nishigaki F; Shimomura K
Arzneimittelforschung; 1989 Aug; 39(8):889-93. PubMed ID: 2818677
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effect of centchroman alone and in combination with glycine soya on 7,12-dimethylbenz[alpha]anthracene-induced breast tumor in rat.
Mishra R; Tiwari A; Bhadauria S; Mishra J; Murthy PK; Murthy PS
Food Chem Toxicol; 2010 Jun; 48(6):1587-91. PubMed ID: 20332012
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activities and estrogen receptor interactions of the metabolites of the antiestrogens C1628 and U23,469 in the 7,12-dimethylbenz(a)anthracene-induced rat mammary tumor system.
Rorke EA; Katzenellenbogen BS
Cancer Res; 1981 Apr; 41(4):1257-62. PubMed ID: 6783294
[No Abstract] [Full Text] [Related]
20. Antitumor effects of SEF19, a new nonsteroidal aromatase inhibitor, on 7,12-dimethylbenz[a]anthracene-induced mammary tumors in rats.
Iino Y; Karakida T; Sugamata N; Andoh T; Takei H; Takahashi M; Yaguchi S; Matsuno T; Takehara M; Sakato M; Kawashima S; Morishita Y
Anticancer Res; 1998; 18(1A):171-6. PubMed ID: 9568073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
